ReviewCNS drugs2014
Natalizumab: risk stratification of individual patients with multiple sclerosis.
Carmen Tur et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ReviewCNS drugs2014
Carmen Tur et al.PubMed ↗Publisher ↗
No numbers read from the abstract.